Home LiteratureArticle Details

PMID: 3568278 Published · ppublish English Letter Research Support, Non-U.S. Gov't

High dose etoposide does not cause peripheral neuropathy.

Cancer chemotherapy and pharmacology ·Vol. 19 ·No. 2 ·1987-00-00 ·Pages 180-1

Littlewood TJ, Bentley DP, McQueen IN

Abstract

暂无摘要

MeSH Terms

Etoposide/administration & dosage,adverse effects Humans Nervous System Diseases/chemically induced,physiopathology Neural Conduction

Chemicals

Etoposide

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Littlewood T J

Bentley D P

McQueen I N

References (5)

5 references, click to expand

Possible enhancement of vincristine neuropathy by VP-16.
Cancer. 1982 Mar 1;49(5):859-64 PMID: 6277454
Review of etoposide.
Clin Pharm. 1983 Mar-Apr;2(2):112-9 PMID: 6309469
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213.
Am J Clin Oncol. 1983 Jun;6(3):327-30 PMID: 6303106
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Cancer. 1975 Apr;35(4):1141-4 PMID: 163675
Etoposide--chemistry, preclinical and clinical pharmacology.
Cancer Treat Rev. 1982 Jun;9 Suppl:3-13 PMID: 7127334

Article Info

Journal

Cancer chemotherapy and pharmacology

Abbr.

Cancer Chemother Pharmacol

ISSN

0344-5704

DOI

Published

1987-00-00

Pages

180-1

Language

English

Region

Germany

NLM ID

7806519

Subset

External Links

Analysis Services